Integra Lifesciences's total assets for Q3 2025 were $3.65B, a decrease of -0.58% from the previous quarter. DE:IL3 total liabilities were $2.61B for the fiscal quarter, a -0.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.